Industry-Supported Symposium Breakfast: Effective Utilization of CAMPS for Wound Closure: Intersecting Evidence with Clinical Decision Making
90 min
Friday, October 04, 2024
7:30 AM - 9:00 AM
Learning Objectives:
- Examine the levels of evidence in wound care, assess how it applies to landscape of CAMPS and its role in informed clinical decision-making - Kirsner
- Identify the importance of prognostic markers for chronic wound healing and when to initiate advanced therapies – Kapp (please include info from Margolis 2000 study - https://pubmed.ncbi.nlm.nih.gov/10936473/. Also Apligraf is the only FDA approved skin sub for VLUs)
- Examine clinical decision making for the use of CAMPS determining then why, how and why – Davis – excellent cases, but expand on why he made the decision to treat with skin subs)
Supported by an educational grant from Organogenesis Inc.
A maximum of 1.0 additional CME/CPME/CE-credit hour is offered through this Industry Supported Symposium. This event is not part of the official SAWC meeting programming and provides separate continuing education credits.
-
Moderator/Speaker
-
Robert Kirsner MD, PhD, FAAD
-
-
Speaker
-
Daniel Davis DPM
-
Daniel Kapp MD
-
-
Room
- Milano V-VI